情欲肉辣h_嗯啊在线观看_高hplay肉np调教_他越弄越深她越叫越大声

Stock(600222)Hot line:010-61006450

News

Understand the latest news of Leadingpharm

Alumni Exchange | CEIBS EMBA 2021 Class 4 Visited Leadingpharm

Release time:2022-08-24

On August 24, 2022, more than 30 students from Class 4 of CEIBS EMBA 2021, led by the class teacher Dan Xia, visited the alumni enterprise Beijing Leadingpharm. Mr. Wallace Tao, Chairman of Leadingpharm and the 2010 alumni of CEIBS EMBA, and Ms. Julie Gao, President of Leadingpharm and classmate of class 4 of CEIBS EMBA 2021, warmly received them.
 

▲ Dan Xia, Head Teacher of Class 4, CEIBS EMBA 2021
 

In her speech, Ms. Dan Xia first expressed her thanks for the full preparation and meticulous arrangement of Leadingpharm. She hoped that the students could deepen their understanding of Leadingpharm and the pharmaceutical industry. She said that Leadingpharm has close ties with CEIBS and hoped that the fate with Leadingpharm will continue in the future. Finally, she wished this event a complete success.
 

▲ Ms. Julie Gao, President of Leadingpharm and Classmate of CEIBS EMBA 2021 Class 4

 

As the organizer of this event, Ms. Julie Gao expressed her thanks to the participation of classmates of CEIBS EMBA 2021 Class 4. She also expressed her gratitude to her senior fellow apprentice,including Chairman of Leadingpharm, Mr. Wallace Tao; Co-founder and Chief Operating Officer of Waytous Intelligence, Lijian Qiu; Co-founder of SicaGene, Mr. Haisheng Wang. Ms. Julie Gao pointed out that as a pharmaceutical R & D company, Leadingpharm hoped that with this visit, all alumni can know more about the pharmaceutical industry and understand the seriousness, innovation and pursuit of excellence of pharmaceutical R & D personnel, which was also the spirit of CEIBS. Took this opportunity to promote better enterprise visits among alumni, enhance friendship among students, and broaden everyone's knowledge of various industries and expand their own cognition and thinking.

 

▲ Mr. Wallace Tao, Chairman of Leadingpharm and the 2010 alumni of CEIBS EMBA; Mr. Pei Yang (right) from CEIBS EU EMBA Admissions Office.
 

Mr. Wallace Tao attended the activity as a 2010 alumnus of CEIBS EMBA, and Mr. Pei Yang from CEIBS EMBA Admissions Office was also invited to attend. They said that the link between everyone and CEIBS was emotional, CEIBS was not only a place for learning knowledge, but also a place for youth, ideals and career.

 

Topic Sharing

 

Ms. Julie Gao shared with the theme of "New Trends in China's Biomedical Industry - Feelings of Innovative R & D Enterprises".

 
The special guest of the activity - Mr. Lijian Qiu, 2020 Alumni of CEIBS EMBA, Co-founder and Chief Operating Officer of Waytous Intelligence, shared with the theme of “Feelings about Mature Companies to Start-ups”.

 

The special guest of the event - Mr. Haisheng Wang, 2018 Alumni of CEIBS EMBA and Co-founder of SicaGene, shared with the theme of “Development Status and Future Trend of China's Nucleic Acid Business”.

 

Mr. Wallace Tao shared with the theme of “CXO Helps Open the All-round Reconstruction of the Underlying Logic of Pharmaceutical Innovation”.

 

▲ Mr. Shenghe Wu, monitor of CEIBS EMBA 2021 Class 4, and student representatives presented souvenirs to Leadingpharm and Speakers.

 

▲ Entering the front line of pharmaceutical research and development, the students of CEIBS EMBA 2021 Class 4visited the pharmaceutical research and development laboratory of Leadingpharm
 

▲ Students and Teachers of CEIBS EMBA 2021 Class 4 in Beijing
 

The visit to Leadingpharm not only deepened the friendship between the alumni of CEIBS, but also made alumni have a deeper understanding of the pharmaceutical industry, as well as the cooperate vision of Leadingpharm, which is “we make China a world-class player in pharmaceutical technology development and production process!”This activity ended in a happy atmosphere. Wish all alumni have great achievements in their studies and have a bright future!
 

-END-


轉(zhuǎn)載聲明:未經(jīng)本網(wǎng)或本網(wǎng)權(quán)利人授權(quán),不得轉(zhuǎn)載、摘編或利用其他方式使用上述作品。已經(jīng)本網(wǎng)或本網(wǎng)權(quán)利人授權(quán)使用作品的,應(yīng)在授權(quán)范圍內(nèi)使用,并注明“來源:新領(lǐng)先醫(yī)藥科技”。

Recommend